BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37905668)

  • 1. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
    Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
    Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of the PRMT5-SND1 Axis in Hepatocellular Carcinoma.
    Wright T; Wang Y; Bedford MT
    Epigenomes; 2021 Mar; 5(1):. PubMed ID: 33768972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
    Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
    J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
    Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
    RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain.
    Liu K; Chen C; Guo Y; Lam R; Bian C; Xu C; Zhao DY; Jin J; MacKenzie F; Pawson T; Min J
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18398-403. PubMed ID: 20937909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
    Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
    Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma.
    Zhou B; Wang Y; Zhang L; Shi X; Kong H; Zhang M; Liu Y; Shao X; Liu Z; Song H; Li W; Gao X; Chang Y; Dou C; Guo W; Zhang S; Kang X; Gao J; Liang Y; Zheng J; Kong E
    Theranostics; 2022; 12(16):6898-6914. PubMed ID: 36276642
    [No Abstract]   [Full Text] [Related]  

  • 9. Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells.
    Arretxe E; Armengol S; Mula S; Chico Y; Ochoa B; Martínez MJ
    Nucleic Acids Res; 2015 Dec; 43(22):10673-88. PubMed ID: 26323317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.
    Santhekadur PK; Das SK; Gredler R; Chen D; Srivastava J; Robertson C; Baldwin AS; Fisher PB; Sarkar D
    J Biol Chem; 2012 Apr; 287(17):13952-8. PubMed ID: 22396537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
    Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
    Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
    Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights Into
    Ochoa B; Chico Y; Martínez MJ
    Front Oncol; 2018; 8():606. PubMed ID: 30619748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice.
    Zhao C; Cui X; Zhao Y; Qian B; Zhang N; Xin L; Ha C; Yang J; Wang X; Gao X
    Bioengineered; 2021 Dec; 12(1):7360-7375. PubMed ID: 34608846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma.
    Chidambaranathan-Reghupaty S; Mendoza R; Fisher PB; Sarkar D
    Hepatoma Res; 2018; 4():. PubMed ID: 32258418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Jariwala N; Rajasekaran D; Mendoza RG; Shen XN; Siddiq A; Akiel MA; Robertson CL; Subler MA; Windle JJ; Fisher PB; Sanyal AJ; Sarkar D
    Cancer Res; 2017 Jun; 77(12):3306-3316. PubMed ID: 28428278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
    Diao C; Guo P; Yang W; Sun Y; Liao Y; Yan Y; Zhao A; Cai X; Hao J; Hu S; Yu W; Chen M; Wang R; Li W; Zuo Y; Pan J; Hua C; Lu X; Fan W; Zheng Z; Deng W; Luo G; Guo W
    Mol Oncol; 2021 Apr; 15(4):1180-1202. PubMed ID: 33305480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
    Liao SY; Rudoy D; Frank SB; Phan LT; Klezovitch O; Kwan J; Coleman I; Haffner MC; Li D; Nelson PS; Emili A; Vasioukhin V
    Nat Commun; 2023 Nov; 14(1):7435. PubMed ID: 37973913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
    Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
    Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
    Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.